agence france-presse
click here to return to agence france-presse main menu
DonateNow



New test keeps US blood supply safer from AIDS, hepatitis: study

Agence France-Presse - August 18, 2004


WASHINGTON, Aug 18 (AFP) - A new method of screening for HIV/AIDS and hepatitis C is making the US blood supply safer, according to a study released Wednesday.

Nucleic acid-amplification testing has detected the virus in instances where its concentration is too small to be picked up by other screening methods, the study by the National Institutes of Health, published in the August 19 issue of the New England Journal of Medicine, showed.

The new state-of-the-art testing method has helped prevent the transmission of HIV/AIDS in five different cases and hepatitis C in 56 cases, on average, per year between 1999 and 2002, according to the study.

The test "enhances the safety of the nation's blood supply by further reducing these risks (of transmitting HIV and hepatitis C)," said Barbara Alving, acting director of the National Heart, Lung, and Blood Institute.

The test is carried out on around 98 percent of the blood collected in the United States.

Researchers said nucleic acid-amplification testing had reduced the risk of HIV/AIDS and hepatitis infections to about one in two million units of blood, compared with one in 1.5 million for HIV and one in 276,000 for hepatitis when less comprehensive screening methods were used.

The new test has also proved effective in detecting emerging viruses. In 2003, it detected traces of the West Nile virus in blood from nearly 1,000 donors, whose donations were then discarded.

040818
AF040855


©AFP 2004.. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

©1990, 2004 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.